September 16, 2014 6:48 PM ET

Pharmaceuticals

Company Overview of Simcere Pharmaceutical Group.

Company Overview

Simcere Pharmaceutical Group engages in the research, development, manufacture, and distribution of pharmaceutical and vaccine products for pharmaceutical distributors and government in the People’s Republic of China. Its principal branded generic pharmaceuticals include Bicun, a prescription edaravone injection pharmaceutical for the treatment of strokes; Zailin, a line of generic prescription amoxicillin antibiotics; Yingtaiqing, an anti-inflammatory pain reliever and analgesic drug used to treat rheumatoid arthritis and osteoarthritis; Yidasheng, a prescription edaravone injection pharmaceutical for the treatment of strokes; and Sinofuan for the treatment of cancer. The company also offer...

No 699-18 Xuan Wu Avenue

Xuan Wu District

Nanjing,  210042

China

Founded in 1995

4,349 Employees

Phone:

86 25 8556 6666

Fax:

86 25 8547 1729

Key Executives for Simcere Pharmaceutical Group.

Chief Executive Officer and Executive Director
Age: 55
Co-Founder and Chairman
Age: 52
Acting Chief Financial Officer
Age: 44
Chief Executive Officer of Simcere MSD (Shanghai) Pharmaceutical Co. Ltd
Age: 51
Executive Vice President
Age: 52
Compensation as of Fiscal Year 2014.

Simcere Pharmaceutical Group. Key Developments

Simcere Pharmaceutical Group. Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014

Simcere Pharmaceutical Group. Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014 . Venue: Kempinski Hotel Suzhou, Suzhou, China.

Simcere Pharmaceutical Group., Annual General Meeting, Dec 19, 2013

Simcere Pharmaceutical Group., Annual General Meeting, Dec 19, 2013., at 09:00 China Standard Time. Location: No.699-18, Xuanwu Avenue. Agenda: To receive a report on the company's operations; and to transact any other business properly brought before the meeting.

Simcere Pharmaceutical Group., Special/Extraordinary Shareholders Meeting, Dec 19, 2013

Simcere Pharmaceutical Group., Special/Extraordinary Shareholders Meeting, Dec 19, 2013., at 10:00 China Standard Time. Location: No. 699-18, Xuan Wu Avenue. Agenda: To consider the proposal to authorize and approve the previously announced agreement and plan of merger.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Simcere Pharmaceutical Group., please visit www.simcere.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.